I agree and understand.
But keep in mind, there is value in the underlying Intellectual Property and Patents.
It then becomes a matter of identifying the potential application of that IP and Patent.
I think the real opportunity for GTG at the moment is to get momentum with their Multi-test product and tap into government subsidised funding, as preventative medicine will save governments lots of money. So GTG management need to build better relationships and/or employ people with those established relationships.
Hopefully EasyDNA will also give them some more global visibility and opportunity for increased sales.
- Forums
- ASX - By Stock
- News: GTG Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent...
I agree and understand.But keep in mind, there is value in the...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
-0.002(4.76%) |
Mkt cap ! $5.816M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 4.0¢ | $137 | 3.425K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6535 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 9786 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 81 | 0.041 |
1 | 6535 | 0.040 |
4 | 130561 | 0.038 |
4 | 86054 | 0.037 |
1 | 13152 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 82 | 1 |
0.042 | 9786 | 1 |
0.044 | 99910 | 1 |
0.045 | 80397 | 3 |
0.047 | 11800 | 1 |
Last trade - 12.25pm 10/09/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |